Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group (Q72717706)
Jump to navigation
Jump to search
scientific article published on 01 November 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group |
scientific article published on 01 November 1994 |
Statements
Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group (English)
J S Petersen
T Dyrberg
A E Karlsen
J Mølvig
B Michelsen
J Nerup
T Mandrup-Poulsen
1 November 1994